# Medtronic Acquires CathWorks AI Coronary Analysis Platform to Lead AI-Powered Cardiac Diagnostics

> ma · REPORTED · 2026-01-01

Medtronic acquired CathWorks, an AI-powered coronary analysis company whose FDA-cleared platform enables real-time physiological assessment of coronary artery disease during catheterization procedures, reinforcing Medtronic's position in AI-enabled cardiac intervention. The deal is part of an accelerating 2025-2026 wave of medtech AI acquisitions driven by stratgic buyers seeking FDA-cleared products with clinical evidence.

About Medtronic: Medtronic is a global medical device leader with broad cardiovascular, neuroscience, surgical, and diabetes portfolios serving hospitals and patients in over 150 countries.

- Company: Medtronic
- Sector: cardiology
- Primary source: https://meddeviceguide.com/blog/ai-powered-medical-devices-funding-acquisition-landscape-2026

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.